Heart Failure & Cardiomyopathy Working Group
Exploring Adverse Cardiac Remodeling
The Working Group is composed of investigators interested in the mechanisms of genetic and acquired heart disease.
Working Group Focus
Hypertrophic cardiomyopathy, dilated cardiomyopathy, heart failure, cardiac hypertrophy, cardiac injury, cardiac remodeling, fibrosis.
The Cardiomyopathy and Heart Failure Working Group is composed of investigators interested in the mechanisms of genetic and acquired heart disease. Researchers in our group are exploring the cellular dysfunction and adverse cardiac remodeling in hypertrophic and dilated cardiomyopathy, as well as acquired form of heart disease resulting from hypertension or underlying coronary heart disease, with the goal of developing effective new therapies for disease prevention. A wide variety of laboratory approaches are being used including stem cell derived human heart tissues in culture, rodent animal models, human patient tissues and clinical data, and computational modeling.
Working Group Members
Daniel E Michele
Ahmed Abdel-latif
Daniel A Beard
Matthew Brody, PhD
Brian Carlson
L Michel Espinoza-Fonseca, PhD
Sascha Goonewardena
Adam Helms, MD
Nageswara Madamanchi
Richard M Mortensen
Anthony Rosenzweig, MD
Yatrik M Shah
Alan Smrcka
Laurie K Svoboda
Andrea D Thompson
Matthias Truttmann PhD
Alison Vander Roest, PhD